Retour page d’accueil • AFYREN, the innovative Greentech for sustainable chemistry, launches its IPO on Euronext Growth® in Paris
AFYREN, the innovative Greentech for sustainable chemistry, launches its IPO on Euronext Growth® in Paris
- A capital increase of approximately €70 million, which may be increased to above €80 million if the extension clause is exercised
- Indicative offering price range: €8.02 to €9.72 per share
- Subscription commitments of €32.66 million to €35.00 million from Bpifrance, Mirova, Sofinnova Biotech Partner 1 and Crédit Agricole Centre France Developpement
- French public offering closes on: 27 September 2021 (at 5.00pm over-the-counter and 8.00pm online)
- Global placement closes on: 28 September 2021 (at 12.00pm)
- Securities eligible for French SME equity savings plans (PEA-PME)
Clermont-Ferrand/Lyon, 14 September 2021 – AFYREN, a greentech company that offers manufacturers natural and low-carbon products produced using a technology based on natural micro-organisms, announces the launch of its IPO with a view to listing its shares on the Paris Euronext Growth® market (ISIN code: FR-0014005AC9 mnemonic: ALAFY).
On 13 September 2021, the French financial markets authority (AMF) approved, under number 21-397, the prospectus for the IPO of AFYREN, comprising the registration document, approved under number I. 21-042 and dated 25 August 2021, a securities note and a summary of the Prospectus (included in the securities note).
Last news
AFYREN awarded Silver Medal by EcoVadis for CSR performance, ranking in the top 8% worldwide
Press release
AFYREN and ESSE Skincare begin partnership to offer 100% natural cosmetic solutions with enhanced skincare performance.
Press release
AFYREN raises €23 million through share capital increase to finance optimization and expansion of unique biorefinery AFYREN NEOXY
Press release
Deforestation – Turning compliance with EUDR into an innovation driver
Publication
Where Nature Meets Performance: The Creative Vision of Delphine Thierry
News post
AFYREN receives €4 million in grants for AFYREN NEOXY and starts new performance-driven investment strategy
Press release